Search

Your search keyword '"Norberg-Spaak, Lena"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Norberg-Spaak, Lena" Remove constraint Author: "Norberg-Spaak, Lena"
47 results on '"Norberg-Spaak, Lena"'

Search Results

2. Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival : implications for treatment

Catalog

Books, media, physical & digital resources

3. Reiterative modeling of combined transcriptomic and proteomic features refines and improves the prediction of early recurrence in squamous cell carcinoma of head and neck

4. Patients with high c‐MYC‐expressing squamous cell carcinomas of the tongue show better survival than those with low‐ and medium‐expressing tumours

6. A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma

8. Levels of MUC1 in tumours and serum of patients with different sub-types of squamous cell carcinoma of the head and neck

9. PD-L1 in squamous cell carcinoma of the oral tongue shows gender-specific association with prognosis

10. Comparison of Preoperative Positron Emission Tomography/Computed Tomography with Panscopy and Ultrasound in Patients with Head and Neck Cancer

11. Health-related quality of life among tonsillar carcinoma patients in Sweden in relation to treatment and comparison with quality of life among the population

12. Comparison of Quality of Life among Patients with Oro-Hypopharyngeal Cancer after Tonsillectomy and Panscopy Using Transoral Robotic Surgery : A Pilot Study

17. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue

18. Copy number variation : A prognostic marker for young patients with squamous cell carcinoma of the oral tongue

19. High podoplanin and low E-cadherin levels correlate with better prognosis in adenoid cystic carcinoma

22. Searching for new targets and treatments in the battle against squamous cell carcinoma of the head and neck, with specific focus on tumours of the tongue

24. Ethnicity based variation in expression of E‑cadherin in patients with squamous cell carcinoma of the oral tongue

25. Transoral Robotic Surgery in the Nordic Countries: Current Status and Perspectives

26. No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue

27. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma

28. Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue

30. No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue

31. Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites

34. Number of negative points : a novel method for predicting radiosensitivity in head and neck tumor cell lines.

35. Radiotherapy response in oral squamous carcinoma cell lines : Evaluation of apoptotic proteins as prognostic factors

36. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells

37. Adenoid cystic carcinoma : Use of cell proliferation, bcl-2 expression, histologic grade, and clinical stage as predictors of clinical outcome

40. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue

43. Ethnicity based variation in expression of E-cadherin in patients with squamous cell carcinoma of the oral tongue

44. Patients with high c-MYC-expressing squamous cell carcinomas of the tongue show better survival than those with low- and medium-expressing tumours

45. High podoplanin and low E-cadherin levels correlate with better prognosis in adenoid cystic carcinoma.

46. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.

47. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.